Products & ProgramsCommercialMay 30, 2018

Coverage Guideline not implemented - Cervical Cancer Screening Using Cytology and Human Papillomavirus Testing (CG-MED-53)

Beginning January 1, 2024, Empire became Anthem. This article, published under the former brand, now applies to Anthem.

In the October 2017 edition of the Network Update, Empire announced a new coverage guideline, Cervical Cancer Screening Using Cytology and Human Papillomavirus Testing (CG-MED-53) to be effective January 1, 2018. Please be advised that CG-MED-53 was not implemented. 

PUBLICATIONS: June 2018 Empire Provider Newsletter